142 related articles for article (PubMed ID: 38383148)
1. Podocyte Disease Following Treatment with Intravenous Ibandronate in an Older Patient.
Chung YR; Lee HS; Lee DY; Lee SH; Jeong JS; Kim B
Ann Geriatr Med Res; 2024 Jun; 28(2):228-230. PubMed ID: 38383148
[TBL] [Abstract][Full Text] [Related]
2. Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.
Jia N; Cormack FC; Xie B; Shiue Z; Najafian B; Gralow JR
BMC Cancer; 2015 Jul; 15():535. PubMed ID: 26197890
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate nephrotoxicity.
Perazella MA; Markowitz GS
Kidney Int; 2008 Dec; 74(11):1385-93. PubMed ID: 18685574
[TBL] [Abstract][Full Text] [Related]
5. [Early initiation of peritoneal dialysis for the treatment of a patient with refractory nephrotic syndrome].
Tsuruga K; Oki E; Suzuki K; Takahashi Y; Tanaka H
Nihon Jinzo Gakkai Shi; 2009; 51(1):68-73. PubMed ID: 19238911
[TBL] [Abstract][Full Text] [Related]
6. Collapsing focal segmental glomerulosclerosis resulting from a single dose of zoledronate.
Neyra JA; Vaidya OU; Hendricks A; Sambandam KK
Nephron Extra; 2014 Sep; 4(3):168-74. PubMed ID: 25473406
[TBL] [Abstract][Full Text] [Related]
7. Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
Guay DR
Pharmacotherapy; 2006 May; 26(5):655-73. PubMed ID: 16637795
[TBL] [Abstract][Full Text] [Related]
8. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis.
Soyaltın E; Demir BK; Alparslan C; Çamlar SA; Alaygut D; Yavaşcan Ö; Mutlubaş F
Turk J Pediatr; 2020; 62(4):663-667. PubMed ID: 32779421
[TBL] [Abstract][Full Text] [Related]
9. Current management strategies for hypercalcemia.
Pecherstorfer M; Brenner K; Zojer N
Treat Endocrinol; 2003; 2(4):273-92. PubMed ID: 15966562
[TBL] [Abstract][Full Text] [Related]
10. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Kolonko A; Piecha G; Więcek A
Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
[TBL] [Abstract][Full Text] [Related]
11. Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis.
Thiébaud D; Burckhardt P; Kriegbaum H; Huss H; Mulder H; Juttmann JR; Schöter KH
Am J Med; 1997 Oct; 103(4):298-307. PubMed ID: 9382122
[TBL] [Abstract][Full Text] [Related]
12. Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluation.
Lewiecki EM; Babbitt AM; Piziak VK; Ozturk ZE; Bone HG
Clin Ther; 2008 Apr; 30(4):605-21. PubMed ID: 18498910
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy, Proteinuria, Plant-Based Supplemented Diets and Focal Segmental Glomerulosclerosis: A Report on Three Cases and Critical Appraisal of the Literature.
Attini R; Leone F; Montersino B; Fassio F; Minelli F; Colla L; Rossetti M; Rollino C; Alemanno MG; Barreca A; Todros T; Piccoli GB
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28753930
[TBL] [Abstract][Full Text] [Related]
14. Anuria after kidney transplantation diagnosed as early recurrence of focal segmental glomerulosclerosis combined with acute calcineurin inhibitor nephrotoxicity: a case report and literature review.
Kim YJ; Lee SW; Kim MS; Kim YJ; Choi JY; Cho JH; Kim CD; Kim YL; Yun WS; Huh S; Lim JH; Park SH
BMC Nephrol; 2024 Apr; 25(1):123. PubMed ID: 38580974
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates for prevention of postmenopausal osteoporosis.
Ravn P
Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
[TBL] [Abstract][Full Text] [Related]
16. Sunitinib-related high-grade proteinuria and allograft dysfunction in a kidney recipient: a rare case report.
Ko HC; Lee HP; Wu JD; Ma TL; Shen CH; Lin CT; Cheng MC; Jou YC
BMC Nephrol; 2022 Apr; 23(1):150. PubMed ID: 35436872
[TBL] [Abstract][Full Text] [Related]
17. Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review.
Miller PD; Ward P; Pfister T; Leigh C; Body JJ
Clin Exp Rheumatol; 2008; 26(6):1125-33. PubMed ID: 19210886
[TBL] [Abstract][Full Text] [Related]
18. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration.
Praga M; Morales E; Herrero JC; Pérez Campos A; Domínguez-Gil B; Alegre R; Vara J; Martínez MA
Am J Kidney Dis; 1999 Jan; 33(1):52-8. PubMed ID: 9915267
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
20. Case report: Unveiling a less severe congenital nephrotic syndrome in a Rapa Nui patient with a
Krall P; Rojo A; Plaza A; Canals S; Ceballos ML; Cano F; Guerrero JL
Front Nephrol; 2024; 4():1379061. PubMed ID: 38808020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
